Comment on "Postmarketing adverse events of tamoxifen in male and female patients with breast cancer". Noguchi Y, Ino Y, Kobayashi R, Yoshimura T, et al. Int J Cancer 2024 Oct 29. doi: 10.1002/ijc.35243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Noguchi Y, Ino Y, Kobayashi R, Yoshimura T, et al. Comment on "Postmarketing adverse events of tamoxifen in male and female patients with breast cancer". Int J Cancer 2024 Oct 29. doi: 10.1002/ijc.35243.
PMID: 39472289